• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

    4/16/25 7:00:00 AM ET
    $ASBP
    $BENF
    $BNZI
    $CIA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $ASBP alert in real time by email

    MIAMI, April 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on April 16 & 17, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1 - Today

    April 16, 2025

    9:00

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:20

    Introduction

    9:25 – 9:35

    Empire Energy (ASX: EEG)

    Keynote speaker: Alex Underwood, CEO & Managing Director

    9:40 – 10:10

    PSQ Holdings, Inc. (NYSE:PSQH)

    Keynote speaker: Michael Seifert, Founder, President / CEO

    10:50 – 11:20

    Ur-Energy (NYSE:URG) (TSX:URE)

    Keynote speaker: John W. Cash, CEO

    11:25 – 11:55

    Interstellar Communication Holdings

    Keynote speakers: Seda Hewitt, Space Ambassador of icMercury, Harri Laitinen, Lifeguard of icMercury, and Lijie Zhu, Captain of icMercury

    12:00 – 12:30

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    12:35 – 1:05

    Odyssey Marine Exploration, Inc. (NASDAQ:OMEX)

    Keynote speaker: Mark D. Gordon, Chairman & CEO

    1:10 – 1:40

    Nova Minerals Limited (NASDAQ:NVA) (ASX: NVA)

    Keynote speaker: Christopher Gerteisen – CEO & Executive Director

    1:45 – 2:15

    C3 Metals Inc. (TSXV:CCCM) (OTCQB:CUAUF)

    Keynote speaker: Daniel A. Symons, President, CEO & Director

    2:20 – 2:50

    Ucore Rare Metals, Inc. (OTCQX:UURAF) (TSXV:UCU)

    Keynote speaker: Pat Ryan, CEO

    2:55 – 3:05

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speaker: Chris Holden – VP Corporate Development

    3:10 – 3:20

    Opawica Explorations Inc. (OTCQB:OPWEF) (TSXV:OPW)

    Keynote speaker: Blake Morgan, President / CEO

    3:25 – 3:35

    HydroGraph Clean Power Inc. (OTCQB:HGRAF) (CSE:HG)

    Keynote speaker: Kjirstin Breure, President and CEO

    3:40 – 3:50

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speaker: David Dodd, Chairman, President / CEO

    _______________________________________________________________

    Day 2 - Tomorrow

    April 17, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    SBC Medical Group Holdings, Inc. (NASDAQ:SBC) 

    Keynote speaker: Yuya Yoshida, Executive Vice President & CFO

    10:50 – 11:20

    Evofem Biosciences, Inc. (OTCQB:EVFM)

    Keynote speaker: Amy Raskopf, Chief Business Development Officer

    11:25 – 11:55

    Bioxytran, Inc. (OTCQB:BIXT) 

    Keynote speakers: Dr. David Platt, CEO & Mike Sheikh, Executive Vice President Business Development

    12:00 – 12:30

    Clene Inc., (NASDAQ:CLNN)

    Keynote speaker: Rob Etherington, President / CEO

    12:35 – 1:05

    Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP)

    Keynote speaker: Kraig Higginson – CEO

    1:10 – 1:40

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    1:45 – 2:15

    Banzai International, Inc. (NASDAQ:BNZI)

    Keynote speaker: Joseph Davy, Co-Founder, Chairman & CEO

    2:55 – 3:05

    Citizens, Inc. (NYSE:CIA)

    Keynote speakers: Jon Stenberg, President / CEO, and Jeff Conklin, CFO

    3:10 – 3:20

    Sono Group N.V. (OTCQB:SEVCF)

    Keynote speaker: George O'Leary, Managing Director, CEO and CFO

    Postponed

    22nd Century Group, Inc. (NASDAQ:XXII)

    Keynote speaker: Lawrence D. Firestone, Chairman & CEO

    3:40 – 3:50

    Alt Equity

    Keynote speaker: Daniel Wait, President / Founder

    3:55 – 4:05

    Cyios Corp. (OTC:CYIO)

    Keynote speaker: John O'Shea, Chairman

    4:10 – 4:20

    Beneficient (NASDAQ:BENF)

    Keynote speaker: Brad K. Heppner, CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ASBP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASBP
    $BENF
    $BNZI
    $CIA

    CompanyDatePrice TargetRatingAnalyst
    Ur Energy Inc
    $URG
    10/27/2025$2.15Outperform
    Northland Capital
    Ur Energy Inc
    $URG
    7/25/2025$3.00Buy
    Maxim Group
    Ur Energy Inc
    $URG
    7/23/2025$2.00Buy
    B. Riley Securities
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    PSQ Holdings Inc.
    $PSQH
    1/15/2025$8.00Buy
    Maxim Group
    GeoVax Labs Inc.
    $GOVX
    11/11/2024$15.00Buy
    Alliance Global Partners
    GeoVax Labs Inc.
    $GOVX
    7/16/2024$20.00Buy
    ROTH MKM
    More analyst ratings

    $ASBP
    $BENF
    $BNZI
    $CIA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cangany Peter T Jr was granted 635,690 shares, increasing direct ownership by 52,711% to 636,896 units (SEC Form 4)

    4 - Beneficient (0001775734) (Issuer)

    12/9/25 9:54:29 PM ET
    $BENF
    Finance: Consumer Services
    Finance

    Director Schnitzer Bruce William was granted 931,837 shares, increasing direct ownership by 48,282% to 933,767 units (SEC Form 4)

    4 - Beneficient (0001775734) (Issuer)

    12/9/25 9:54:15 PM ET
    $BENF
    Finance: Consumer Services
    Finance

    Director Sawyer Jon D was granted 4,854 shares, increasing direct ownership by 6% to 79,580 units (SEC Form 4)

    4 - ODYSSEY MARINE EXPLORATION INC (0000798528) (Issuer)

    12/9/25 4:05:04 PM ET
    $OMEX
    Marine Transportation
    Consumer Discretionary

    $ASBP
    $BENF
    $BNZI
    $CIA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Ur-Energy with a new price target

    Northland Capital initiated coverage of Ur-Energy with a rating of Outperform and set a new price target of $2.15

    10/27/25 8:50:37 AM ET
    $URG
    Precious Metals
    Basic Materials

    Maxim Group initiated coverage on Ur-Energy with a new price target

    Maxim Group initiated coverage of Ur-Energy with a rating of Buy and set a new price target of $3.00

    7/25/25 8:21:07 AM ET
    $URG
    Precious Metals
    Basic Materials

    B. Riley Securities resumed coverage on Ur-Energy with a new price target

    B. Riley Securities resumed coverage of Ur-Energy with a rating of Buy and set a new price target of $2.00

    7/23/25 8:05:14 AM ET
    $URG
    Precious Metals
    Basic Materials

    $ASBP
    $BENF
    $BNZI
    $CIA
    SEC Filings

    View All

    Ur Energy Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

    8-K - UR-ENERGY INC (0001375205) (Filer)

    12/15/25 5:15:16 PM ET
    $URG
    Precious Metals
    Basic Materials

    SEC Form 6-K filed by Nova Minerals Limited

    6-K - Nova Minerals Ltd (0001852551) (Filer)

    12/15/25 4:41:25 PM ET
    $NVA
    Precious Metals
    Basic Materials

    PSQ Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement

    8-K - PSQ Holdings, Inc. (0001847064) (Filer)

    12/15/25 4:06:05 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    $ASBP
    $BENF
    $BNZI
    $CIA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ASBP
    $BENF
    $BNZI
    $CIA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Odyssey Marine Exploration's Unsolicited Request for a U.S. Offshore Mineral Lease Sale Advances as BOEM Initiates Formal Review Process

    A year of policy alignment, project advancement, and balance-sheet strengthening sets the stage for continued progress in 2026 Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a U.S.-based ocean exploration and marine resource development leader, received news that the Bureau of Ocean Energy Management's (BOEM), a department of the U.S. Department of Interior (DOI) has initiated the formal review process for its unsolicited request for a potential marine mineral lease sale in federal waters offshore Virginia. "BOEM's decision to initiate this process is an important step toward responsibly evaluating the mineral potential of the U.S. Outer Continental Shelf," said Mark Gordon, Chairman and

    12/15/25 8:30:00 AM ET
    $GLDD
    $OMEX
    Military/Government/Technical
    Industrials
    Marine Transportation
    Consumer Discretionary

    SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares

    Strategic acquisition strengthens SBC's comprehensive service offerings and R&D capabilities SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services for medical organizations, today announced the final results of its tender offer for common shares of Waqoo, Inc. (TYO:4937) (the "Tender Offer"), a medical research and development company specializing in regenerative medicine technologies, listed on the Tokyo Stock Exchange Growth Market. The tender offer, which commenced on November 14, 2025 and concluded on December 12, 2025, was conducted at JPY 1,900 per share. Through the Tender Offer,

    12/12/25 11:00:00 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Beneficient Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price

    DALLAS, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF), a technology-enabled platform providing liquidity and related trust and custody services to holders of alternative assets, today announced a 1-for-8 reverse stock split (the "Reverse Stock Split") of its Class A common stock, par value $0.001 per share (the "Class A Common Stock"), and its Class B common stock, par value $0.001 per share ("Class B Common Stock" and together with the Class A Common Stock, the "Common Stock"). The Reverse Stock Split was previously approved by Beneficient's stockholders on December 1, 2025. Beneficient's Class A Common Stock will continue to trade on The Nasdaq Capital Market ("Nasdaq") un

    12/11/25 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    $ASBP
    $BENF
    $BNZI
    $CIA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Seifert Michael Stephen bought $10,000 worth of shares (7,143 units at $1.40), increasing direct ownership by 6% to 133,955 units (SEC Form 4)

    4 - PSQ Holdings, Inc. (0001847064) (Issuer)

    12/1/25 7:10:54 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    VICE PRESIDENT FINANCE Walle Jade bought $182,880 worth of shares (144,000 units at $1.27) (SEC Form 4)

    4 - UR-ENERGY INC (0001375205) (Issuer)

    11/21/25 5:06:49 PM ET
    $URG
    Precious Metals
    Basic Materials

    Chief People Officer Hebert Michael Robert sold $36,130 worth of shares (23,310 units at $1.55) and bought $15,102 worth of shares (9,400 units at $1.61), decreasing direct ownership by 4% to 252,876 units (SEC Form 4)

    4 - PSQ Holdings, Inc. (0001847064) (Issuer)

    11/17/25 8:08:29 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    $ASBP
    $BENF
    $BNZI
    $CIA
    Leadership Updates

    Live Leadership Updates

    View All

    PublicSquare to Host Virtual Analyst & Investor Day on Thursday, September 25, 2025

    PSQ Holdings, Inc. (NYSE:PSQH) ("PublicSquare" or the "Company") announced today that the Company will host a virtual analyst and investor day on Thursday, September 25, 2025 from 11:00 a.m. ET to 1:00 p.m. ET. The Company will post slides and other supporting material to its website on the day of the event. Michael Siefert, Chief Executive Officer, Dusty Wunderlich, Chief Strategy Officer and other members of the executive leadership team will discuss strategic fintech initiatives, long-term plans related to digital assets, and business outlook followed by an interactive question-and-answer session. The analyst and investor day will be broadcast live through a link on the PublicSquare

    9/3/25 7:00:00 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    PublicSquare Partners With Silencer Shop, Bringing Its Fintech Solutions to the Largest Distributor of Suppressors in the Nation

    PSQ Holdings, Inc. (NYSE:PSQH) ("PublicSquare" or the "Company") is pleased to announce a partnership between its fintech segment and Silencer Shop, the largest distributor of suppressors in the United States. Suppressors are one of the fastest‑growing segments of the firearms industry, and this collaboration marks a pivotal advancement in delivering innovative payments and credit solutions to an industry often underserved by traditional financial providers. Through this partnership, PublicSquare's bundled payments and credit solution will be seamlessly integrated into the Silencer Shop platform, bringing enhanced technological capabilities and financial services to their extensive custom

    8/20/25 7:00:00 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    PublicSquare Grateful for Closure of Politically Motivated CFPB Investigation into Credova

    Closure affirms Credova and PublicSquare's responsible and transparent operations supporting the Second Amendment End of this Biden-era, politically motivated investigation is a victory for freedom, for business, and for every American who refuses to yield to government overreach PSQ Holdings, Inc. (NYSE:PSQH) ("PublicSquare" or the "Company") was pleased to receive notification from the Consumer Financial Protection Bureau ("CFPB") that it had formally closed the investigation into Credova Financial, LLC ("Credova"), a wholly owned subsidiary of PublicSquare. As the Bureau confirmed to Credova, it was closing the investigation because it "has determined that this investigation exem

    8/19/25 3:24:00 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    $ASBP
    $BENF
    $BNZI
    $CIA
    Financials

    Live finance-specific insights

    View All

    Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8®

    FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8Biomarker improvements are strongly associated with longer survival, reinforcing CNM-Au8's potential disease modifying activityCompany has requested a Type C meeting in the first quarter of 2026 to present the newly completed analyses supporting a planned NDA submission under the accelerated approval pathwayClene is hosting an investor webcast today at 8:30 am ET SALT LAKE CITY, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene" or the "Company") and its wholly owned subsidiary Clene Nanomedicine, Inc., a late clinic

    12/3/25 8:00:00 AM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Beneficient Reports Results for Second Quarter Fiscal 2026

    DALLAS, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2026 second quarter, which ended September 30, 2025. Commenting on the fiscal 2026 second quarter results, interim Chief Executive Officer James Silk said: "The second quarter results demonstrate our disciplined approach to managing both our investment portfolio and operating expenses during a pivotal period for Beneficient. We reduced expenses, completed new primary capital transaction

    11/14/25 5:15:00 PM ET
    $BENF
    Finance: Consumer Services
    Finance

    Banzai Reports Third Quarter 2025 Financial Results

    Revenue of $2.8 Million for Q3 2025, up 163% from Q3 2024 Gross Profit of $2.3 Million for Q3 2025, a 213% increase from Q3 2024; Gross Margin Expanded to 81.7% in Q3 2025, a 1,302 BPS Increase Management to Host Third Quarter 2025 Results Conference Call Today, Friday, November 14, 2025 at 4:30 p.m. Eastern Time SEATTLE, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ:BNZI) ("Banzai" or the "Company"), a leading marketing technology company that provides essential marketing and sales solutions, today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 and Subsequent Key Financial & Operational Highlights

    11/14/25 4:10:00 PM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    $ASBP
    $BENF
    $BNZI
    $CIA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PSQ Holdings Inc.

    SC 13G - PSQ Holdings, Inc. (0001847064) (Subject)

    12/12/24 11:50:43 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    11/14/24 5:56:57 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care